Sanofi SA (ADR) (NYSE:SNY) Adds Gene Therapy Project And $300 Million To Selecta Deal

Sanofi SA (ADR) (NYSE:SNY) has added $300 million to its collaboration with Selecta Biosciences to develop a vaccination for the treatment of celiac disease and achieve other research innovations. The company is also mulling to join hands with Genethon to making the treatments safe across diverse categories if the need arises. Selecta has also entered […]